ArticleFuture oncology (London, England)2025

Real-world treatment outcomes of abemaciclib in older patients with HR+, HER2- metastatic breast cancer in Japan.

Tatsunori Shimoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.